VT ablation
Sponsors
Abbott Medical Devices, Biotronik SE & Co. KG, Heinrich-Heine University, Duesseldorf, St George's, University of London, Beijing Anzhen Hospital
Conditions
Atrial Fibrillation (AF)Coronary Artery DiseaseIschemic CardiomyopathyLeft Ventricular DysfunctionReduced LVEFVentricular TachycardiaVentricular Tachycardia (VT)
Unknown Phase
Substrate Modification in Stable Ventricular Tachycardia in Addition to Implantable Cardioverter Defibrillator (ICD) Therapy
CompletedNCT00919373
Start: 2002-07-31End: 2006-01-31Updated: 2019-02-04
Preventive aBlation of vEntricular tachycaRdia in Patients With myocardiaL INfarction
TerminatedNCT02501005
Start: 2015-07-20End: 2018-07-20Updated: 2019-07-08
Catheter Ablation for Nonsustained Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy
NCT03147027
Start: 2017-05-02End: 2020-12-31Target: 72Updated: 2020-06-25
Multimodality Assessment of Ventricular Scar Arrhythmogenicity.
CompletedNCT04632394
Start: 2021-03-01End: 2024-04-02Updated: 2025-05-30
Complex Arrhythmia Registry
RecruitingNCT07024927
Start: 2025-10-21End: 2032-06-01Target: 4000Updated: 2026-06-04